Literature DB >> 16005833

A pilot study of therapeutic massage for people with Parkinson's disease: the added value of user involvement.

Charlotte Paterson1, Jeffrey A Allen, Margaret Browning, Gillian Barlow, Paul Ewings.   

Abstract

OBJECTIVE: To carry out a pilot study, with particular attention to adequacy of outcome measures.
DESIGN: Observational study and user participation. SETTING AND PARTICIPANTS: A local user group selected seven participants with a wide range of illness severity. INTERVENTION: A course of eight 1hr sessions of deep whole body (therapeutic) massage over 8 weeks. OUTCOME MEASURES: The Parkinson's Disease Questionnaire (PDQ-39), the Measure Yourself Medical Outcome Profile (MYMOP), and the Medication Change Questionnaire (MCQ). Semi-structured interviews, before and after the intervention.
RESULTS: In addition to enjoying the massage, individuals showed improvement in self-confidence, well-being, walking and activities of daily living. There was good agreement between data from the outcome questionnaires, interviews and clinical notes. User involvement highlighted issues that would otherwise have been ignored.
CONCLUSIONS: The study confirms the benefits of involving users in the research process and makes recommendations concerning the design of any future randomised trial.

Entities:  

Mesh:

Year:  2005        PMID: 16005833     DOI: 10.1016/j.ctcp.2004.12.008

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  17 in total

1.  The 39-Item Parkinson's Disease Questionnaire (PDQ-39): Is it a Unidimensional Construct?

Authors:  Peter Hagell; Maria H Nilsson
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  User involvement in the development of a research bid: barriers, enablers and impacts.

Authors:  Sophie Staniszewska; Nicola Jones; Mary Newburn; Shanit Marshall
Journal:  Health Expect       Date:  2007-06       Impact factor: 3.377

Review 3.  Mechanisms for alternative treatments in Parkinson's disease: acupuncture, tai chi, and other treatments.

Authors:  Bijan D Ghaffari; Benzi Kluger
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

4.  A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.

Authors:  Danny Bega; Paulina Gonzalez-Latapi; Cindy Zadikoff; Tanya Simuni
Journal:  Curr Treat Options Neurol       Date:  2014-10       Impact factor: 3.598

5.  Active Patient Engagement: Long Overdue in Rehabilitation Research.

Authors:  Samantha Louise Harrison; Dina Brooks
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

Review 6.  Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Marian L Evatt
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

Review 7.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

8.  Self-reported efficacy of cannabis and other complementary medicine modalities by Parkinson's disease patients in colorado.

Authors:  Taylor Andrew Finseth; Jessica Louise Hedeman; Robert Preston Brown; Kristina I Johnson; Matthew Sean Binder; Benzi M Kluger
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

Review 9.  Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices.

Authors:  Danny Bega; Cindy Zadikoff
Journal:  J Mov Disord       Date:  2014-10-30

10.  Narratives reflecting the lived experiences of people with brain disorders: common psychosocial difficulties and determinants.

Authors:  Sally Hartley; Maggie McArthur; Michaela Coenen; Maria Cabello; Venusia Covelli; Joanna Roszczynska-Michta; Tuuli Pitkänen; Jerome Bickenbach; Alarcos Cieza
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.